SEC Form 4 · accession 0001127602-18-011591
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T Lenehan
Director
Period of report
Mar 13, 2018
Accepted (ET)
Mar 14, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 13, 2018 | M | 1,590 | $50.34 | A | 48,334 | D | |
| Ordinary Shares | Mar 13, 2018 | S | 1,306 | $83.555 | D | 47,028 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $50.34 | Mar 13, 2018 | M | 1,590 | D | — | Apr 28, 2018 | Ordinary Shares | 1,590 | 0 | D |
Explanation of responses
- F1This balance increased 391 shares due to exempt transactions such as dividend reinvestment.
- F2This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.